Peopl e in higher social classes have better facilities for maintaining good health, [1] [2] [3] and tend to respond to health education and modify their health habits more readily than those in lower classes. [4] [5] [6] It is thus easy to assume that among people with a chronic disease like diabetes, which necessitates health behaviour changes and the patient's active responsibility for treatment, wider socioeconomic differences in health would prevail than in the general population. However, this assumption was not supported by an earlier Finnish study indicating no major socioeconomic differences in mortality among diabetic people in the early 1980s, despite a clear gradient in the non-diabetic population. 7 The most likely explanation according to the authors was that around the study period diabetic Finns displayed no major differences between social classes in terms of health behaviour, quality of treatment and other important factors related to risk of death. However, two recent British studies, 8, 9 and three earlier studies including only subjects with insulin-dependent diabetes mellitus, [10] [11] [12] revealed a clear socioeconomic mortality gradient in diabetic people. One of the British studies critizised the Finnish findings for the absence of information about risk factors for socioeconomic disparities in mortality, and having no information about type of diabetes or use of insulin. 8 This study explored socioeconomic mortality differences in the diabetic population in Finland in 1991-1996 and compared them to corresponding findings from the early 1980s. The study design was improved over the earlier Finnish study by using the age at onset as proxy for the patient's type of diabetes. The non-diabetic population in Finland was also included in analyses, allowing comparison of changes in socioeconomic mortality gradients between people with and without diabetes.
METHODS

Study data
In our analyses we were able to combine the dataset from 1981-1985 used in the earlier Finnish study 7 with a new dataset from 1991-1996. The study populations comprised all people aged 30 to 74 years in the 1980 and 1990 censuses in Finland, and those who reached 30 during follow-up. Persons' ages were updated in the follow-up, and those reaching 75 were thereafter excluded from the analyses. Deaths in the study populations in 1981-1985 and 1991-1996 were obtained from the national register of causes of death. Information on cause of death was limited to the underlying cause. In 1981-1985 causes of death in Finland were classified according to ICD-8 (International Classification of Diseases, 8 th revision), in 1991 according to ICD-9, and in 1996 according to ICD-10. The 1991 diagnoses were converted to ICD-8 codes to give comparable information on the mortality changes between these two follow-up periods. Data on persons suffering from diabetes at the end of 1980 and 1990 came from the register of the Finnish Social Insurance Institution on entitlements for reimbursement for antidiabetic medication. 13, 14 Patients with insulindependent diabetes are entered in the register almost immediately after diagnosis. Patients with non-insulindependent diabetes are first treated by diet for at least three months; if this fails to achieve normoglycaemia the patient enters the national drug register and thereafter receives drug treatment free of charge. The new dataset based on the 1990 census allowed us to obtain data on the patient's age at the time she/he entered the register. This corresponds closely with age at onset of diabetes, particularly for the insulin-dependent type. In analyses, patients whose reimbursement for diabetes medication started before the age of 30 were considered to have insulin-dependent diabetes (type 1), and those with onset after 40 years were considered non-insulindependent (type 2). According to a Finnish study, 92% of patients under 30 years of age at diagnosis had insulindependent diabetes. Of all insulin-dependent diabetes patients, 15% were over 30 years old at the time of diagnosis. 15 To improve our proxy for type 2 diabetes, we left those aged 30 to 39 years at onset of reimbursement out of these specific analyses. Since Finland's current health insurance system was introduced in 1964, we had no information on type of diabetes for persons with onset before that year. For this reason, the oldest persons in our data set who could be defined as type 1 diabetic patients were 29 years old in 1964 and reached 60 years in 1994 or 1995. Therefore mortality comparisons between type 1 and type 2 diabetic people were restricted to those aged 40-59 years during the study period. All register data were individually linked using personal identification numbers, and subsequently anonymized by Statistics Finland. The data in 1981-1985 comprised 230,000 person years and 11,215 deaths for people with diabetes, and 12,400,000 person years and 102,843 deaths for those without diabetes. The 1991-1996 dataset included 316,000 person years and 13,447 deaths in the diabetic and 16,500,000 person years and 111,198 deaths in the non-diabetic population. Since the mortality follow-up was based on the approved entitlements for reimbursement for antidiabetic medication at the end of 1980 and 1990, there were few deaths (166 in 1981-1985 and 155 in 1991-1996) from diabetes among people defined as non-diabetic in the study. For them, diabetes was diagnosed after the start of the follow-up. Social classes were constructed from the socioeconomic classification routinely used by Statistics Finland, 16 in which social class is based on occupation at the beginning of the follow-up for people who are economically active, and on earlier occupation for retired and unemployed people. The occupation of the head of the household was used for those with no such information available. 'Upper white-collar workers' roughly correspond to class I in the British Registrar General's classification, 17 'lower whitecollar workers' to classes II and III (N), and 'blue-collar workers' to classes III (M), IV and V. 'Farmers' refer to all people who receive their main income from farming, regardless of farm size or number of employees. All other self-employed people, employers and those with no data on social class were classified as 'others'.
Statistical analysis
Mortality by social class in the diabetic and non-diabetic population was age-adjusted for the European standard population using the direct standardization method. 18 Statistical significance of differences in mortality in 1981-1985 and 1991-1996 was tested with the Poisson regression. Due to small numbers, mortality from specific causes of death was analysed only for blue-collar workers and the aggregated group of upper and lower white-collar workers. In the 1991-1996 data, age-standardized mortality was also calculated by the patient's type of diabetes. These relative death rates were obtained from Poisson regression models including age (in five-year groups) as a categorical variable. The impact of each cause of death on the increase in socioeconomic differences in all-cause mortality from 1981-1985 to 1991-1996 was obtained on the basis of the directly age-standardized death rates, calculating the proportion of the change in the overall mortality difference attributable to the change in the cause-specific mortality difference. 1981-1985 to 1991-1996 age-standardized allcause mortality decreased in both groups, but less so among diabetic people. While mortality decreased by 16% and 22% among non-diabetic women and men, the corresponding reductions in the diabetic population were 6% and 14% (table 1). In 1981-1985 the diabetic population's mortality did not reveal any major social class differences, while a clear trend existed among non-diabetic people (figure 1). However, in the 1990s the relative socioeconomic differences in mortality were equally large for diabetic and non-diabetic women. In diabetic men, mortality differences also appeared, but in relative terms they remained smaller than among non-diabetic men. The mortality of white-collar workers and farmers decreased by 24-29% in both diabetic and non-diabetic men. In blue-collar and other groups, however, the mortality decline was much smaller among diabetic men (table 1) . Among non-diabetic women mortality declined markedly in both white-collar and blue-collar workers, but in diabetic women mortality increased both among blue-collar workers and the 'others'. The mortality increase among diabetic blue-collar women was due to rising mortality in the 30-54 age groups. Socioeconomic mortality disparities among diabetic people increased in almost all major causes of death included in table 2. In 1981-1985 mortality among diabetic blue-collar workers was not significantly higher than among diabetic white-collar workers except for lung Socioeconomic mortality and diabetic people cancer in men, but in the 1990s blue-collar workers' excess mortality was statistically significant in almost all causes of death. Nevertheless, relative social class differences in mortality among diabetic people in 1991-1996 remained smaller than in the non-diabetic population for most causes of death (table 2) . The divergent socioeconomic mortality among diabetic people between 1981-1985 and 1991-1996 was mainly due to widening disparities in deaths from diabetes and cardiovascular diseases (table 3) . Among non-diabetic men aged 40-59, socioeconomic differences in all-cause mortality were larger than among type 2 diabetic men (p=0.0007) (table 4). There were no statistically significant differences in the socioeconomic mortality gradient between type 1 and type 2 diabetic men, and between the three groups of women. Among women and men with type 2 diabetes, the socioeconomic mortality gradient was mainly due to circulatory diseases (56% for women, 34% for men) and to diabetes (16% and 10%). For type 1 diabetic men, circulatory diseases contributed 48% and diabetes 34% of the mortality disparities between blue-and white-collar men. Among women with type 1 diabetes, the socioeconomic mortality gradient was mainly due to diabetes (42%). Circulatory diseases did not contribute to the socioeconomic mortality gradient among type 1 diabetic women.
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Between the early 1980s and 1990s in Finland a clear socioeconomic gradient in mortality emerged in every age Table 1 Age standardized mortality a by social class among diabetic and non-diabetic people aged 30-74, Finland 1981 30-74, Finland -1985 30-74, Finland and 1991 30-74, Finland -1996 Diabetic population Non-diabetic population 1981-1985 1991-1996 1981-1985 1991-1996 Deaths n Figure 1 Age-specific mortality among diabetic (DM) and non-diabetic (non-DM) white-collar and blue-collar workers in Finland, 1981 Finland, -1985 Finland, and 1991 Finland, -1996 EUROPEAN JOURNAL OF PUBLIC HEALTH VOL. 13 2003 NO. 1 group of diabetic people, due to a sharper decrease in mortality among white-collar than blue-collar workers. Among female blue-collar workers with diabetes mortality even increased. In the non-diabetic population the mortality decline was larger and rather similar for all socioeconomic groups. Recent UK and Danish studies on diabetic people's socioeconomic disparities in mortality have shown similar results to ours for the 1990s. 8, 9, 12 Our results did not support the UK finding of greater social class differences in mortality among type 2 than type 1 diabetic people. 9 However, the UK study was not based on a representative population sample as it followed mortality in diabetic people of working age who attended eight diabetic clinics within one year. The validity of data based on the linkage of registers on entitlements of drug reimbursements and mortality was debated 8 after the publication of the earlier Finnish study 7 indicating no major socioeconomic differences in mortality among diabetic people in the early 1980s. It was argued that the exclusion of people with diet-treated diabetes, as well as the possibly higher proportion of diabetic people with insulin-dependent diabetes in the higher social classes, may artificially attenuate the socioeconomic mortality gradient. 8 These potential biases, however, would be expected to have only a minor impact on younger diabetic people, most of whom suffer from type 1 diabetes. As no socioeconomic gradient was found in the Finnish data for 1981-85 among diabetic women aged 30-49 and only a small gradient among men of the same age, it seems unlikely that these possible sources of error explained the lack of socioeconomic mortality differences among diabetic people in Finland in the 1980s. 19 In the present study we used a combined data set consisting of the data used in the previous study from the early Table 2 Age standardized mortality (95% confidence interval) of blue-collar workers compared to white-collar workers a ( = 1.00) by cause of death among diabetic and non-diabetic people aged 30-74 in Finland, 1981 30-74 in Finland, -1985 30-74 in Finland, and 1991 30-74 in Finland, -1996 Diabetic population Non-diabetic population 1981-1985 1991-1996 1981-1985 1991-1996 a: Consisting of both upper and lower white-collar workers. b: Some cause of death groups had no deaths in younger age groups, so these were combined with the next upper age group using the same age group combinations for diabetic and non-diabetic groups and the two follow-up periods. All causes 100 100 a: Consisting of both upper and lower white-collar workers.
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1980s, and a new data set from the early 1990s formed using an identical linkage scheme. In addition, by including information on the age at onset of drug imbursement, we were able to divide the diabetic population into those who very probably had type 1 diabetes and those who most likely had type 2 diabetes. According to our knowledge, no major changes in the indications for medical treatment of type 2 diabetes have occurred in Finland during the past two decades, and therefore the results obtained from the data sets for the 1980s and the 1990s should be comparable. According to our study, the increasing socioeconomic mortality disparities among diabetic people were mainly due to a divergent trend in deaths from diabetes, and secondly from cardiovascular mortality. In the early 1980s, when a socioeconomic gradient in mortality from diabetes was not found, the quality of medical care and glycaemic control of diabetes may have been similar across all social groups in Finland. As the treatment of diabetes developed, e.g. via the introduction of new methods of determining glycated haemoglobin concentration and new practices for administering insulin, the potential to attain proper glycaemic control improved markedly by the early 1990s. 20 Because those in higher social classes tend to be more receptive to health education and modifying their habits than those in lower classes, 4-6 they might have found it easier to adopt the new treatment practices for diabetes and benefitted more from the improved care. In the Netherlands, for example, diabetic people with low education have lower utilization rates for health checks and medical services relevant to diabetes care, and worse outcomes in terms of complications. 21 In addition, Finland experienced a very severe economic recession in the early 1990s, which caused reductions in overall health care spending as well as cuts in preventive health services in municipal primary health care centres. As a consequence the quality of public diabetes care may have deteriorated, 22 which might have affected the worse-off more.
In the general population in Finland, most of the decline in mortality from cardiovascular diseases from the 1970s to 1990s has been related to changes in coronary risk factors. [23] [24] [25] The established coronary risk factors appear also to be very important in the aetiology of cardiovascular disease in the diabetic population. 26, 27 The increase in socioeconomic disparities in mortality from cardiovascular diseases in the diabetic population may result from changes in risk factor levels or other factors affecting the incidence or prognosis of cardiovascular diseases. Unfortunately, we lack time series data by social class on risk factors, incidence and prognosis of cardiovascular disease among diabetic persons. The results concerning the early 1980s suggest that among diabetic Finns there were no major differences between social classes in health behaviour, quality of treatment and other factors influencing the prognosis of the disease. In the early 1990s, the situation was no longer the same. Substantial socioeconomic mortality differentials had emerged also in the diabetic population, due to a reduction in mortality in the upper classes while in the lower socioeconomic strata very little progress was observed among men and a small increase in mortality occurred among women. In the early 1980s, the treatment of diabetes, including efforts to reduce cardiovascular risk factors, may well have been quite similar in all socioeconomic strata because the municipal health centres, providing primary health care for the great majority of the population, had more or less adequate resources and kept a: Consisting of both upper and lower white-collar workers. b: Some cause of death groups among women had no deaths in some age groups, so these were combined with the next upper age group using the same age group combinations for type 1 and type 2 diabetic and non-diabetic groups.
EUROPEAN JOURNAL OF PUBLIC HEALTH VOL. 13 2003 NO. 1 up a system of specialized nurses who were in charge of the primary health care of diabetic individuals. The substantial cuts in municipal health centres, during the severe economic recession at the beginning of the 1990s, are likely to have affected the worse-off more, as higher social classes have had better possibilities to use the services provided by the private sector. In addition, diabetic people of higher social classes may have benefitted more from the improvements in the medical treatment of diabetes since the early 1980s. The results of our study suggest that it is possible to reduce substantially the socioeconomic differences in the prognosis of a severe chronic disease, such as diabetes, by ensuring that adequate services for treatment and prevention of complications are provided for all sectors of the population.
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